These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27702574)

  • 1. Cell-free analysis of polyQ-dependent protein aggregation and its inhibition by chaperone proteins.
    Machida K; Shigeta T; Kobayashi A; Masumoto A; Hidaka Y; Imataka H
    J Biotechnol; 2016 Dec; 239():1-8. PubMed ID: 27702574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.
    Gillis J; Schipper-Krom S; Juenemann K; Gruber A; Coolen S; van den Nieuwendijk R; van Veen H; Overkleeft H; Goedhart J; Kampinga HH; Reits EA
    J Biol Chem; 2013 Jun; 288(24):17225-37. PubMed ID: 23612975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interaction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1 modulates aggregation.
    Monsellier E; Redeker V; Ruiz-Arlandis G; Bousset L; Melki R
    J Biol Chem; 2015 Jan; 290(5):2560-76. PubMed ID: 25505179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable delivery system containing a peptide inhibitor of polyglutamine aggregation: a step toward therapeutic development in Huntington's disease.
    Joshi AS; Thakur AK
    J Pept Sci; 2014 Aug; 20(8):630-9. PubMed ID: 24788406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of Chaperone-Mediated Effects on Polyglutamine Protein Aggregation by the Filter Trap Assay.
    van Waarde-Verhagen MAWH; Kampinga HH
    Methods Mol Biol; 2018; 1709():59-74. PubMed ID: 29177651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.
    Nagai Y; Fujikake N; Popiel HA; Wada K
    Curr Pharm Biotechnol; 2010 Feb; 11(2):188-97. PubMed ID: 20166962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
    Kubota H; Kitamura A; Nagata K
    Methods; 2011 Mar; 53(3):267-74. PubMed ID: 21195182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRCP1 Conveys Resistance to Polyglutamine Aggregation.
    Santarriaga S; Haver HN; Kanack AJ; Fikejs AS; Sison SL; Egner JM; Bostrom JR; Seminary ER; Hill RB; Link BA; Ebert AD; Scaglione KM
    Mol Cell; 2018 Jul; 71(2):216-228.e7. PubMed ID: 30029002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting DNA topoisomerases or checkpoint kinases results in an overload of chaperone systems, triggering aggregation of a metastable subproteome.
    Huiting W; Dekker SL; van der Lienden JCJ; Mergener R; Musskopf MK; Furtado GV; Gerrits E; Coit D; Oghbaie M; Di Stefano LH; Schepers H; van Waarde-Verhagen MAWH; Couzijn S; Barazzuol L; LaCava J; Kampinga HH; Bergink S
    Elife; 2022 Feb; 11():. PubMed ID: 35200138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
    Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
    J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].
    Nagai Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):913-6. PubMed ID: 20030247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV; Lazarev VF; Kaznacheeva AV; Ippolitova MV; Muronetz VI; Kinev AV; Margulis BA
    Hum Mol Genet; 2011 Oct; 20(20):3953-63. PubMed ID: 21775503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N terminus of the small heat shock protein HSPB7 drives its polyQ aggregation-suppressing activity.
    Wu D; Vonk JJ; Salles F; Vonk D; Haslbeck M; Melki R; Bergink S; Kampinga HH
    J Biol Chem; 2019 Jun; 294(25):9985-9994. PubMed ID: 31097540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach.
    Hay DG; Sathasivam K; Tobaben S; Stahl B; Marber M; Mestril R; Mahal A; Smith DL; Woodman B; Bates GP
    Hum Mol Genet; 2004 Jul; 13(13):1389-405. PubMed ID: 15115766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens.
    Rozales K; Younis A; Saida N; Meller A; Goldman H; Kellerman L; Heinrich R; Berlin S; Shalgi R
    Nat Commun; 2022 Jan; 13(1):516. PubMed ID: 35082301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.
    Meriin AB; Zhang X; He X; Newnam GP; Chernoff YO; Sherman MY
    J Cell Biol; 2002 Jun; 157(6):997-1004. PubMed ID: 12058016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntingtin Polyglutamine-Dependent Protein Aggregation in Reconstituted Cells.
    Machida K; Kanzawa K; Shigeta T; Yamamoto Y; Tsumoto K; Imataka H
    ACS Synth Biol; 2018 Feb; 7(2):377-383. PubMed ID: 29232946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.